Curcumin: from ancient medicine to current clinical trials

Area of Science:

• Pharmacology and Natural Products Chemistry

Background:

• Curcumin is the principal bioactive compound derived from turmeric (Curcuma longa), a widely used spice and traditional remedy.
• It possesses a diverse array of beneficial biological activities, including anti-inflammatory, antioxidant, chemopreventive, and chemotherapeutic properties.

Purpose of the Study:

• To explore the multifaceted therapeutic potential of curcumin.
• To elucidate the molecular mechanisms underlying curcumin's pleiotropic effects.

Main Methods:

• Review of curcumin's chemical properties and interactions with biological systems.
• Analysis of curcumin's influence on key cellular signaling pathways (e.g., NF-kappaB, Akt, Nrf2).
• Examination of curcumin's role as a free radical scavenger, antioxidant, and metal chelator.

Main Results:

• Curcumin demonstrates significant anti-inflammatory and antioxidant activities.
• It modulates critical survival, cytoprotective, metastatic, and angiogenic pathways.
• Curcumin exhibits metal-binding and iron-chelating capabilities.
• The compound is well-tolerated, with low toxicity, though bioavailability is limited.

Conclusions:

• Curcumin's complex chemistry underlies its ability to impact multiple signaling pathways.
• Despite limited bioavailability, curcumin shows considerable promise as a therapeutic agent.
• Ongoing human clinical trials are investigating curcumin's efficacy for conditions such as cancer and Alzheimer's disease.